Abstract 3371: Preclinical disposition and pharmacokinetics of volitinib, a novel selective cMet inhibitor .

Title
Abstract 3371: Preclinical disposition and pharmacokinetics of volitinib, a novel selective cMet inhibitor .
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 73, Issue 8 Supplement, Pages 3371-3371
Publisher
American Association for Cancer Research (AACR)
Online
2014-08-15
DOI
10.1158/1538-7445.am2013-3371

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now